Interleukin-6 is a potential therapeutic target in interleukin-6 dependent, estrogen receptor-α-positive breast cancer

References

• SansonePStorciGTavolariSIL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary glandJ Clin Invest2007117123988400218060036
   PubMed Web of Science ®Google Scholar
• StudebakerAWStorciGWerbeckJLFibroblasts isolated from common sites of breast cancer metastasis enhance cancer cell growth rates and invasiveness in an interleukin-6-dependent mannerCancer Res200868219087909518974155
   PubMed Web of Science ®Google Scholar
• TisdaleMJCachexia in cancer patientsNat Rev Cancer200221186287112415256
   PubMed Web of Science ®Google Scholar
• Van RheeFStoneKSzmaniaSBarlogieBSinghZCastleman disease in the 21st century: an update on diagnosis, assessment, and therapyClin Adv Hematol Oncol20108748649820864917
   PubMedGoogle Scholar
• De LucaALamuraLGalloMMaffiaVNormannoNMesenchymal stem cell-derived interleukin-6 and vascular endothelial growth factor promote breast cancer cell migrationJ Cell Biochem2012113113363337022644871
   PubMed Web of Science ®Google Scholar
• SullivanNJSasserAKAxelAEInterleukin-6 induces an epithelial-mesenchymal transition phenotype in human breast cancer cellsOncogene200928332940294719581928
   PubMed Web of Science ®Google Scholar
• XieGYaoQLiuYIL-6-induced epithelial-mesenchymal transition promotes the generation of breast cancer stem-like cells analogous to mammosphere culturesInt J Oncol20124041171117922134360
   PubMed Web of Science ®Google Scholar
• ChaveyCBibeauFGourgou-BourgadeSOestrogen receptor negative breast cancers exhibit high cytokine contentBreast Cancer Res200791R1517261184
   PubMed Web of Science ®Google Scholar
• ChiuJJSgagiasMKCowanKHInterleukin 6 acts as a paracrine growth factor in human mammary carcinoma cell linesClin Cancer Res1996212152219816109
   PubMed Web of Science ®Google Scholar
• SasserAKSullivanNJStudebakerAWHendeyLFAxelAEHallBMInterleukin-6 is a potent growth factor for ER-alpha-positive human breast cancerFASEB J200721133763377017586727
   PubMed Web of Science ®Google Scholar
• WalterMLiangSGhoshSHornsbyPJLiRInterleukin 6 secreted from adipose stromal cells promotes migration and invasion of breast cancer cellsOncogene200928302745275519483720
   PubMed Web of Science ®Google Scholar
• BachelotTRay-CoquardIMenetrier-CauxCRastkhaMDucABlayJYPrognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patientsBr J Cancer200388111721172612771987
   PubMed Web of Science ®Google Scholar
• SalgadoRJuniusSBenoyICirculating interleukin-6 predicts survival in patients with metastatic breast cancerInt J Cancer2003103564264612494472
   PubMed Web of Science ®Google Scholar
• WonHSKimYALeeJSSoluble interleukin-6 receptor is a prognostic marker for relapse-free survival in estrogen receptor-positive breast cancerCancer Invest201331851652123902164
   PubMed Web of Science ®Google Scholar
• DeMicheleAGrayRHornMHost genetic variants in the interleukin-6 promoter predict poor outcome in patients with estrogen receptor-positive, node-positive breast cancerCancer Res200969104184419119435922
   PubMed Web of Science ®Google Scholar
• SnoussiKStrosbergADBouaouinaNBenASChouchaneLGenetic variation in pro-inflammatory cytokines (interleukin-1beta, interleukin-1alpha and interleukin-6) associated with the aggressive forms, survival, and relapse prediction of breast carcinomaEur Cytokine Netw200516425326016464738
   PubMed Web of Science ®Google Scholar
• IacopettaBGrieuFJosephDThe −1174 G/C gene polymorphism in interleukin-6 is associated with an aggressive breast cancer phenotypeBr J Cancer200490241942214735187
   PubMed Web of Science ®Google Scholar
• SasserAKMundyBLSmithKMHuman bone marrow stromal cells enhance breast cancer cell growth rates in a cell line-dependent manner when evaluated in 3D tumor environmentsCancer Lett2007254225526417467167
   PubMed Web of Science ®Google Scholar
• StoneKWoodsESzmaniaSMInterleukin-6 receptor polymorphism is prevalent in HIV-negative Castleman disease and is associated with increased soluble interleukin-6 receptor levelsPLoS One201381e5461023372742
   PubMed Web of Science ®Google Scholar
• ChaturvediSSiegelDWagnerCLDevelopment and validation of panoptic Meso scale discovery assay to quantify total systemic interleukin-6Br J Clin Pharmacol201580468769725847183
   PubMed Web of Science ®Google Scholar
• MouawadRBenhammoudaARixeOEndogenous interleukin 6 levels in patients with metastatic malignant melanoma: correlation with tumor burdenClin Cancer Res199628140514099816314
   PubMed Web of Science ®Google Scholar
• AngstwurmMWGartnerRZiegler-HeitbrockHWCyclic plasma IL-6 levels during normal menstrual cycleCytokine1997953703749195137
   PubMed Web of Science ®Google Scholar
• YamamuraMYamadaYMomitaSKamihiraSTomonagaMCirculating interleukin-6 levels are elevated in adult T-cell leukaemia/lymphoma patients and correlate with adverse clinical features and survivalBr J Haematol199810011291349450801
   PubMed Web of Science ®Google Scholar
• JiangXPYangDCElliottRLHeadJFReduction in serum IL-6 after vacination of breast cancer patients with tumour-associated antigens is related to estrogen receptor statusCytokine200012545846510857759
   PubMed Web of Science ®Google Scholar
• WongEFreibergMTracyRKullerLEpidemiology of cytokines: the women on the move through activity and nutrition (WOMAN) studyAm J Epidemiol2008168444345318579536
   PubMed Web of Science ®Google Scholar
• van RheeFWongRSMunshiNSiltuximab for multicentric Castleman’s disease: a randomised, double-blind, placebo-controlled trialLancet Oncol201415996697425042199
   PubMed Web of Science ®Google Scholar
• WegielBBjartellACuligZPerssonJLInterleukin-6 activates PI3K/Akt pathway and regulates cyclin A1 to promote prostate cancer cell survivalInt J Cancer200812271521152918027847
   PubMed Web of Science ®Google Scholar
• LeuCMWongFHChangCHuangSFHuCPInterleukin-6 acts as an antiapoptotic factor in human esophageal carcinoma cells through the activation of both STAT3 and mitogen-activated protein kinase pathwaysOncogene200322497809781814586407
   PubMed Web of Science ®Google Scholar
• IrizarryRABolstadBMCollinFCopeLMHobbsBSpeedTPSummaries of Affymetrix GeneChip probe level dataNucleic Acids Res2003314e1512582260
   PubMed Web of Science ®Google Scholar
• DaiMWangPBoydADEvolving gene/transcript definitions significantly alter the interpretation of GeneChip dataNucleic Acids Res20053320e17516284200
   PubMed Web of Science ®Google Scholar
• KauffmannAGentlemanRHuberWarrayQualityMetrics – a bioconductor package for quality assessment of microarray dataBioinformatics200925341541619106121
   PubMedGoogle Scholar
• TalloenWClevertDAHochreiterSI/NI-calls for the exclusion of non-informative genes: a highly effective filtering tool for microarray dataBioinformatics200723212897290217921172
   PubMed Web of Science ®Google Scholar
• SmythGKLinear models and empirical bayes methods for assessing differential expression in microarray experimentsStat Appl Genet Mol Biol20043 Article3
   PubMedGoogle Scholar
• RhodesLVMuirSEElliottSAdult human mesenchymal stem cells enhance breast tumorigenesis and promote hormone independenceBreast Cancer Res Treat2010121229330019597705
   PubMed Web of Science ®Google Scholar
• RhodesLVAntoonJWMuirSEElliottSBeckmanBSBurowMEEffects of human mesenchymal stem cells on ER-positive human breast carcinoma cells mediated through ER-SDF-1/CXCR4 crosstalkMol Cancer2010929521087507
   PubMed Web of Science ®Google Scholar
• BerishajMGaoSPAhmedSStat3 is tyrosine-phosphorylated through the interleukin-6/glycoprotein 130/Janus kinase pathway in breast cancerBreast Cancer Res200793R3217531096
   PubMed Web of Science ®Google Scholar
• EdgarRDomrachevMLashAEGene expression omnibus: NCBI gene expression and hybridization array data repositoryNucleic Acids Res200230120721011752295
   PubMed Web of Science ®Google Scholar
• OsborneCKCoronado-HeinsohnEBHilsenbeckSGComparison of the effects of a pure steroidal antiestrogen with those of tamoxifen in a model of human breast cancerJ Natl Cancer Inst199587107467507563152
   PubMed Web of Science ®Google Scholar